Antibiotics Market Research Report Contains Global Industry Dynamics 2019: Opportunities, Risk and Driving Force forecast to 2024

Posted on Nov 8 2019 6:59 AM

"Global Antibiotics Industry research report studies latest Antibiotics aspects market size, share, trends, industry summary and Antibiotics growth during the forecast period (2019-2024). The study report comprehensively determines several aspects which are very significant while observing global market on a minute level which contains analysis over arise of Antibiotics industry along with year-on-year manufacturing advancement, business environment and evolution rate over the years. "

Global “Antibiotics Market” is an overview of the global market is provided with prime focus on factors boosting and hampering market. This will help investors get a clear understanding on which aspects to focus on and how to economically support the market globally. The impact of prevailing regulatory scenario on both regional and worldwide Antibiotics market is provided detail in this report.

Market Summary:

  • The global antibiotics market was valued at USD 42,653.89 million in 2018, and is estimated to be valued at USD 56,369.92 million in 2024, witnessing a CAGR of 4.7%. Certain factors that are driving the market growth include the emergence of anti-MRSA drugs, development of generic drugs, and vulnerable aging population.
  • A company that initially produced the patented drug tries to generate maximum revenue before the patent expires. Once the patent expires, there will be many competitors who begin manufacturing the generic formulations. They have the same composition and same pharmacological activities as of the original drug. Almost 80% of the prescription antibiotics are generic. As a result of this, the price is reduced. More people can afford drugs, thus, resulting in improved healthcare outcomes. However, indiscriminate drug usage also leads to drug resistance and other complications.

Get a Sample Copy of the Report -

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report:

  • GlaxoSmithKline PLC
  • Johnson & Johnson Inc.
  • Merck & Co. Inc.
  • Pfizer Inc.
  • Bayer Healthcare AG
  • Novartis AG
  • Sanofi SA
  • Abbott Laboratories
  • Roche Holding AG

Scope of the Report:

  • As per the , antibiotic medicines are among the most prescribed courses worldwide, in fighting bacterial infections, primarily in outpatient settings.

Market Dynamics: –

  • Drivers: (Developing regions and growing markets)
  • Limitations: (Regional, Key Player facing Issues, Future Barriers for growth)
  • Opportunities: (Regional, Growth Rate, Competitive, Consumption)

The report provides key statistics on the market status of the Antibiotics Market manufacturers and is a valuable source of guidance and direction for companies and individuals interested in the Antibiotics.

For More Information or Query or Customization Before Buying, Visit at -

Key questions answered in the report include:

  • What will the market size and the growth rate be in 2024?
  • What are the key factors driving the global Antibiotics market?
  • What are the key market trends impacting the growth of the global Antibiotics market?
  • What are the challenges to market growth?
  • Who are the key vendors in the global Antibiotics market?
  • What are the market opportunities and threats faced by the vendors in the global Antibiotics market?
  • Trending factors influencing the market shares of the relevant regions.
  • What are the key outcomes of the five forces analysis of the global Antibiotics market?

Key Market Trends:

Carbapenems are Expected to Show the Rapid Growth of in the Future.

The cephalosporin segment is expected to account for the largest market size during the forecast period. Carbapenems are expected to witness the highest CAGR of around 5.9% during the forecast period.

The rising threat of drug resistance and a weak pipeline of new molecules are leading to the development of combinational formulations. For instance, in countries, like India, the emergence of multi-drug-resistant tuberculosis (TB) is a major factor driving the R&D expenditures. Methicillin-resistant Staphylococcus aureus (MRSA) is another bacterium responsible for several infections in humans that are difficult to treat. The MRSA infection is difficult to treat with standard antibiotics, such as penicillins (methicillin, dicloxacillin, nafcillin, and oxacillin), and the cephalosporins. In 2014, the US Food and Drug Administration (FDA) approved four new antibiotics for the treatment of infections caused by gram-positive bacteria, including MRSA.

North America is Expected to Dominate the Market in the Forcasted Period

North America currently dominates the market for antibiotics and is expected to continue its stronghold for a few more years. This region is expected to increase its market share in the future, owing to the increased adoption of antibiotics. The United States holds the majority of the market in the North American region, due to the fact that the United States has the highest antibiotic prescribing rate in the North American region. In addition, there is a rise in per capita health expenditure in the country, which is expected to increase over the forecast period, owing to decrease in the unemployment rate.

Purchase this Report (Price 4250 USD for single user license) -

Study objectives of Antibiotics Market Report:

  • To provide a detailed analysis of the market structure along with the forecast of various segments and sub-segments of the Antibiotics market
  • To provide insights into factors influencing and affecting market growth
  • To provide historical, current, and forecast revenue of market segments based on material, type, design, and end user
  • To provide historical, current, and forecast revenue of market segments and sub-segments with respect to regional markets and key countries
  • To provide strategic profiling of key players in the market, comprehensively analyzing their market shares, core competencies, and drawing a competitive landscape for the market
  • To provide economic factors, technology trends, and market trends that influence the global Antibiotics market

Detailed TOC of Antibiotics Market Report 2019-2024:

1.1 Study Deliverables
1.2 Study Assumptions
1.3 Scope of the Study



4.1 Market Overview
4.2 Market Drivers
4.2.1 Emergence of Anti-MRSA/VRE Drugs
4.2.2 Development of Generic Drugs
4.2.3 Vulnerable Aging Population
4.3 Market Restraints
4.3.1 Antibiotic Resistance
4.3.2 Fewer Companies Involved in Active Research
4.3.3 Time Taken for Regulatory Approval
4.4 Industry Attractiveness of Porter's Five Forces Analysis

5.1 By Product Type
5.1.1 Cephalosporins
5.1.2 Penicillins
5.1.3 Fluroquinilones
5.1.4 Macrolides
5.1.5 Carbapenems
5.1.6 Aminoglycosides
5.1.7 Sulfonamides
5.1.8 Other Product Types
5.2 By Spectrum
5.2.1 Broad-spectrum Antibiotics
5.2.2 Narrow-spectrum Antibiotics
5.3 Geography
5.3.1 North America United States Canada Mexico
5.3.2 Europe France Germany United Kingdom Italy Spain Rest of Europe
5.3.3 Asia-Pacific China Japan India Australia South Korea Rest of Asia-Pacific
5.3.4 Middle East & Africa GCC South Africa Rest of Middle East & Africa
5.3.5 South America Brazil Argentina Rest of South America

6.1 Company Profiles
6.1.1 GlaxoSmithKline PLC
6.1.2 Johnson & Johnson Inc.
6.1.3 Merck & Co. Inc.
6.1.4 Pfizer Inc.
6.1.5 Bayer Healthcare AG
6.1.6 Novartis AG
6.1.7 Sanofi SA
6.1.8 Abbott Laboratories
6.1.9 Roche Holding AG


Contact Us:

Name: Ajay More

Phone: US +14242530807/ UK +44 20 3239 8187

Email: [email protected]